Value Sense
NTRA
Natera, Inc. (NTRA)
Last Price$143.1(8.0%)
Market Cap$18.5B
LTM Cost of Goods Sold (COGS)
$648.6M
YoY Growth
+14.6%
3Y CAGR
+31.7%
5Y CAGR
+30.1%
Stock quality & Intrinsic value
6/10
50.4% overvalued
NTRA
is (50.4%) overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Natera, Inc. Cost of Goods Sold (COGS)

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Cost of Goods Sold (COGS)
$11.2M
$37.3M
$78.4M
$112.8M
$135.6M
$139.6M
$166.1M
$175.5M
$203.6M
$318.4M
$456.3M
$589.8M
NTRA
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for NTRA and see if it's the right time to invest.
Dive in

Natera, Inc. (NTRA) Cost of Goods Sold (COGS) comparison analysis

General

LTM Cost of Goods Sold (COGS)

Growth

Company name

YoY growth

3Y CAGR

5Y CAGR

Natera, Inc. logo
Natera, Inc.NTRA
$648.6M
14.6%
31.7%
30.1%
Median Peer Set
$4,448.5M
1.4%
1.5%
5.2%
Thermo Fisher Scientific Inc. logo
Thermo Fisher Scientific Inc.TMO
$25.1B
(0.8%)
9.8%
12.6%
IQVIA Holdings Inc. logo
IQVIA Holdings Inc.IQV
$10.6B
5.0%
4.6%
7.7%
Danaher Corporation logo
Danaher CorporationDHR
$9,669.0M
(1.9%)
(5.6%)
1.8%
Laboratory Corporation of America Holdings logo
Laboratory Corporation of America HoldingsLH
$9,506.8M
0.4%
(3.2%)
2.7%
Quest Diagnostics Incorporated logo
Quest Diagnostics IncorporatedDGX
$6,672.0M
7.7%
0.5%
5.8%
Agilent Technologies, Inc. logo
Agilent Technologies, Inc.A
$2,225.0M
(33.1%)
(9.1%)
(1.6%)
Mettler-Toledo International Inc. logo
Mettler-Toledo International Inc.MTD
$1,583.2M
2.3%
0.8%
4.5%
IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc.IDXX
$1,516.9M
3.1%
4.6%
7.8%
Illumina, Inc. logo
Illumina, Inc.ILMN
$1,511.0M
(14.1%)
3.3%
7.0%
Waters Corporation logo
Waters CorporationWAT
$1,236.5M
2.4%
2.3%
4.1%

NTRA key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
% growth
14.3
0.0%
55.2
287.2%
159.3
188.7%
190.4
19.5%
217.1
14.0%
210.9
(2.8%)
257.7
22.1%
302.3
17.3%
391.0
29.3%
625.5
60.0%
820.2
31.1%
1,082.6
32.0%
Cost of Goods Sold (COGS)11.237.378.4112.8135.6139.6166.1175.5203.6318.4456.3589.8
Gross Profit
% margin
3.1
21.7%
17.9
32.4%
80.9
50.8%
77.5
40.7%
81.5
37.5%
71.3
33.8%
91.6
35.6%
126.9
42.0%
187.4
47.9%
307.1
49.1%
364.0
44.4%
492.7
45.5%
Operating Expenses22.343.280.2137.3178.0205.4206.2257.5403.7775.2905.0939.0
Research & Development Expenses (R&D)7.011.617.327.741.950.151.451.4100.0264.2316.4320.7
Selling, General & Administrative Expenses (SG&A)15.331.662.9109.6136.1155.3154.9206.2303.6511.0588.6618.3
Operating Income
% margin
(19.2)
(134.8%)
(25.3)
(45.8%)
0.7
0.4%
(59.8)
(31.4%)
(96.5)
(44.4%)
(134.0)
(63.5%)
(114.6)
(44.5%)
(130.7)
(43.2%)
(216.3)
(55.3%)
(468.2)
(74.8%)
(541.0)
(66.0%)
(446.2)
(41.2%)
Interest Income57.00.00.11.01.42.40.04.27.65.43.524.4
Interest Expense0.011.94.23.50.54.210.510.715.18.39.312.6
Pre-tax Income(76.2)(37.1)(5.2)(70.3)(95.6)(135.9)(127.8)(122.8)(229.6)(471.1)(546.8)(434.5)
Income Tax
% effective tax rate
0.0
0.0%
12.0
(32.4%)
2.5
(48.6%)
(9.9)
14.1%
0.1
(0.1%)
0.5
(0.3%)
0.3
(0.3%)
2.0
(1.6%)
0.1
(0.0%)
0.6
(0.1%)
1.0
(0.2%)
0.3
(0.1%)
Net Income
% margin
(76.2)
(534.5%)
(37.1)
(67.3%)
(5.2)
(3.2%)
(70.3)
(36.9%)
(95.8)
(44.1%)
(136.3)
(64.6%)
(128.2)
(49.7%)
(124.8)
(41.3%)
(229.7)
(58.8%)
(471.7)
(75.4%)
(547.8)
(66.8%)
(434.8)
(40.2%)
EPS(24.37)(1.01)(0.14)(2.68)(1.86)(2.56)(2.22)(1.79)(2.84)(5.21)(5.57)(3.78)
Diluted EPS(24.37)(1.01)(0.14)(2.68)(1.86)(2.54)(2.22)(1.79)(2.84)(5.21)(5.57)(3.78)
EBITDA
% margin
(18.5)
(129.8%)
(22.7)
(41.2%)
4.2
2.6%
(61.2)
(32.2%)
(93.4)
(43.0%)
(125.8)
(59.6%)
(107.1)
(41.6%)
(104.4)
(34.5%)
(206.0)
(52.7%)
(451.5)
(72.2%)
(520.8)
(63.5%)
(383.3)
(35.4%)

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Natera, Inc.'s Cost of Goods Sold (COGS)?

As of today, Natera, Inc.'s last 12-month Cost of Goods Sold (COGS) is $648.6M, based on the financial report for Sep 30, 2024 (Q3’2024).

2) What is Natera, Inc.'s Cost of Goods Sold (COGS) growth rate?

Over the last year, Natera, Inc.'s Cost of Goods Sold (COGS) growth was 14.6%. The average annual Cost of Goods Sold (COGS) growth rates for Natera, Inc. have been 42.2% over the past three years, 30.1% over the past five years.

3) Is Natera, Inc.'s Cost of Goods Sold (COGS) growth rate Good?

Over the last year, Natera, Inc.'s Cost of Goods Sold (COGS) growth was 14.6%, which is higher than industry growth of 0.0%. It indicates that Natera, Inc.'s Cost of Goods Sold (COGS) growth is Good.

4) How does Natera, Inc.'s Cost of Goods Sold (COGS) growth rate compare to its peers?

Over the last year, Natera, Inc.'s Cost of Goods Sold (COGS) growth was 14.6%, which is higher than peer median growth of (6.5%). The list of peers includes TMO, IQV, DHR, LH, DGX, A, MTD, IDXX, ILMN, WAT etc.